Bluebird Bio Performance
| BLUEDelisted Stock | USD 4.97 0.23 4.85% |
The firm shows a Beta (market volatility) of 0.0828, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bluebird Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bluebird Bio is expected to be smaller as well. Bluebird Bio right now shows a risk of 0.0%. Please confirm Bluebird Bio semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Bluebird Bio will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bluebird Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bluebird Bio is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Bluebird |
Bluebird Bio Relative Risk vs. Return Landscape
If you would invest 497.00 in Bluebird Bio on November 13, 2025 and sell it today you would earn a total of 0.00 from holding Bluebird Bio or generate 0.0% return on investment over 90 days. Bluebird Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Bluebird, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bluebird Bio Target Price Odds to finish over Current Price
The tendency of Bluebird Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.97 | 90 days | 4.97 | about 9.65 |
Based on a normal probability distribution, the odds of Bluebird Bio to move above the current price in 90 days from now is about 9.65 (This Bluebird Bio probability density function shows the probability of Bluebird Stock to fall within a particular range of prices over 90 days) .
Bluebird Bio Price Density |
| Price |
Predictive Modules for Bluebird Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bluebird Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluebird Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bluebird Bio is not an exception. The market had few large corrections towards the Bluebird Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bluebird Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bluebird Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.61 | |
β | Beta against Dow Jones | 0.08 | |
σ | Overall volatility | 0.53 | |
Ir | Information ratio | 0.07 |
Bluebird Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bluebird Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bluebird Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bluebird Bio is not yet fully synchronised with the market data | |
| Bluebird Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.81 M. Net Loss for the year was (240.72 M) with profit before overhead, payroll, taxes, and interest of 28.19 M. | |
| Bluebird Bio currently holds about 132.51 M in cash with (260.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72. |
Bluebird Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bluebird Stock often depends not only on the future outlook of the current and potential Bluebird Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluebird Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.7 M | |
| Cash And Short Term Investments | 62.3 M |
Bluebird Bio Fundamentals Growth
Bluebird Stock prices reflect investors' perceptions of the future prospects and financial health of Bluebird Bio, and Bluebird Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bluebird Stock performance.
| Return On Equity | -5.47 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.92) % | |||
| Operating Margin | (0.56) % | |||
| Current Valuation | 158.07 M | |||
| Shares Outstanding | 9.79 M | |||
| Price To Earning | (19.32) X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 83.81 M | |||
| EBITDA | (156.82 M) | |||
| Cash And Equivalents | 132.51 M | |||
| Cash Per Share | 1.72 X | |||
| Total Debt | 358.24 M | |||
| Debt To Equity | 1.63 % | |||
| Book Value Per Share | (5.91) X | |||
| Cash Flow From Operations | (260.02 M) | |||
| Earnings Per Share | (20.59) X | |||
| Total Asset | 460.23 M | |||
| Retained Earnings | (4.5 B) | |||
| Current Asset | 523.97 M | |||
| Current Liabilities | 40.37 M | |||
About Bluebird Bio Performance
By analyzing Bluebird Bio's fundamental ratios, stakeholders can gain valuable insights into Bluebird Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bluebird Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bluebird Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people.Things to note about Bluebird Bio performance evaluation
Checking the ongoing alerts about Bluebird Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bluebird Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bluebird Bio is not yet fully synchronised with the market data | |
| Bluebird Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.81 M. Net Loss for the year was (240.72 M) with profit before overhead, payroll, taxes, and interest of 28.19 M. | |
| Bluebird Bio currently holds about 132.51 M in cash with (260.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72. |
- Analyzing Bluebird Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bluebird Bio's stock is overvalued or undervalued compared to its peers.
- Examining Bluebird Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bluebird Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bluebird Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bluebird Bio's stock. These opinions can provide insight into Bluebird Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Bluebird Stock
If you are still planning to invest in Bluebird Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bluebird Bio's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |